Latest PDE5 inhibitors Stories
New clients are invited to use the services of a web pharmacy that has been created recently to provide customers with the most popular drugs, like generic Cialis, for the most competitive prices. Las Vegas, NV (PRWEB) December 3, 2010 It is natural that all customers using the services of online pharmacies would like to get high quality medicines, paying less for them and getting their order within the shortest possible time.
MOUNTAIN VIEW, Calif., Nov. 8, 2010 /PRNewswire-FirstCall/ -- VIVUS, Inc. (Nasdaq: VVUS) today announced that it has closed the sale of its MUSE business to Meda.
Viagra, the famous little blue pill that millions of men use for erectile dysfunction, and originally developed to help ailing hearts, may now also help treat heart symptoms of muscular dystrophy.
MOUNTAIN VIEW, Calif., Oct. 4 /PRNewswire-FirstCall/ -- VIVUS, Inc. (Nasdaq: VVUS) today announced that it has entered into an asset purchase agreement with Meda - an international specialty pharma company - for MUSEÂ®, transurethral alprostadil, for the treatment of erectile dysfunction (ED).
Drug companies have not only sponsored the science of a new condition known as female sexual dysfunction, they have helped to construct it, in order to build global markets for new drugs, reveals an article in this week's BMJ.
CRANBURY, N.J., Aug. 17 /PRNewswire-FirstCall/ -- Palatin Technologies, Inc.
The Milwaukee Teachers' Education Association union is asking a judge to force the region's school board to reinstate Viagra and other erectile dysfunction drugs to their taxpayer-funded health care coverage.
MOUNTAIN VIEW, Calif., Aug. 5 /PRNewswire-FirstCall/ -- VIVUS, Inc. (Nasdaq: VVUS) today announced that Timothy Morris, chief financial officer, will present an overview of the company at the Bank of America Merrill Lynch 2010 Specialty Pharmaceuticals Conference.
CRANBURY, N.J., June 24 /PRNewswire-FirstCall/ -- Palatin Technologies, Inc.
The drug industryâ€™s latest attempt to find a female equivalent to Viagra fell short in two separate studies, according to federal regulators on Wednesday.
- To say in too many words; to express verbosely.
- To express in too many words: sometimes used reflexively.
- The leading idea or a repeated phrase, as of a song or ballad; the refrain; burden.